跳至主要内容
临床试验/NCT03251573
NCT03251573已完成不适用

The Cohort Study of Cognitive Impairment and Its Association With Clinical Outcomes in Chinese Maintenance Hemodialysis Patients

Beijing Shijitan Hospital, Capital Medical University1 个研究点 分布在 1 个国家目标入组 613 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
613
试验地点
1
主要终点
cognitive function

研究概览

简要总结

This study is going to apply neuropsychological battery tests to measure cognitive function across multiple cognitive domains in our cohort of 600 maintenance hemodialysis patients and evaluate:

  1. The presence and patterns of cognitive impairment in domains of executive function, perceptual-motor function, language, learning and memory, and complex attention;
  2. Clinical characteristics of participants with and without cognitive impairment;
  3. the risk factors which might be related to cognitive impairment in this group of population;
  4. The association between cognitive impairment and all-cause mortality, stroke and non-fatal cardiovascular events;

We hypothesize that hemodialysis patient is going to have cognitive impairment which might be associated with some risk factors. We also anticipate that cognitive impairment might have some kind of association with the clinical outcomes like all-cause mortality, stroke and other common clinical outcomes that we mentioned above.

详细描述

Neuropsychological assessment All neuropsychological assessments were performed by the research staff that was centrally trained and certified by the study neuropsychologist to conduct the assessments before study commencement. All research staff and patients were native Chinese speakers. Neuropsychological assessment was conducted individually in a separate room on the day after a dialysis session and required on average approximately 90 minutes. Global cognitive function was screened by the Chinese Beijing version of the Montreal Cognitive Assessment (MoCA-BJ).10 The comprehensive battery of neuropsychological tests was designed to assess five cognitive domains: (1) attention/processing speed, using Symbol Digit Modalities Test and the Chinese modified version of the Trail Making Test A,11,12(2) executive function, using the Chinese modified version of the Trail Making Tests B , and a modified version of the Stroop Color-Word Test;13 (3) verbal memory, using the Chinese version of the Auditory Verbal Learning Test for short-delay and long-delay free recall14 and Complex Figure for visual memory (delayed recall test; Chinese version);12 (4) language, using the Chinese modified versions of Boston Naming Test (the 30-item version) and Animal Fluency Test;15,16and (5) visuospatial function, using the Rey-Osterrieth Complex Figure (copy test).17,18 Depression was assessed using the Hamilton Depression Scale, with scores ranging from 0 to 63 and a score of 7 or above suggested as the optimal cutoff for suspected depression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects have end-stage kidney disease and are treated with long-term outpatient haemodialysis in each investigational site for at least the previous 3 months;
  • 50 ~ 80 years old;
  • willing to provide written and informed consent.

排除标准

  • Subjects have disturbance of consciousness or mental disorder;
  • Subjects have sensory (visual and hearing) or motor impairment, which disabled them to complete the tests that required these senses;
  • Subjects have a life expectancy less than 6 months according to their physician, have a planned kidney transplantation within 6 months of baseline, or have anticipated recovery of kidney function.

结局指标

主要结局

cognitive function

时间窗: This measurement is going to be completed within 3 months after the first participant enrolls.

This study is going to apply neuropsychological battery tests to measure cognitive function across multiple cognitive domains

次要结局

未报告次要终点

研究者

发起方
Beijing Shijitan Hospital, Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Luo, Chief, MD, PhD

Director of nephrology

Beijing Shijitan Hospital, Capital Medical University

研究点 (1)

Loading locations...

相似试验